Depression care has several front doors, and each opens onto a different hallway. If you are helping a spouse, parent, or adult child in St. Peters whose depression has not lifted on standard medication, it helps to know what is behind each one before you knock.
In June 2026, 443 adults across ten Midwest states told our poll which door they would knock on first to pursue ketamine or esketamine care. The final, validated results produced a clear ranking. Here is how those doors compare from a caregiver's point of view.
The ranking at a glance
- Their regular doctor: 56 percent
- A psychiatry practice: 23 percent
- Researching online solo: 12 percent
- A friend's advice: 1 percent
- Stuck, with no starting point: 5 percent
Below, four doors compared, including the one a family member represents.
Door one: the primary care doctor
Why people choose it: Familiarity. More than half of our respondents picked it, and a doctor's nod was the most convincing voice for 74 percent.
What it is good for: Reviewing the medication history, ruling out physical contributors like thyroid problems or sleep disorders, adjusting prescriptions, and starting a referral. The primary office also holds the records that insurers often want before approving treatment for depression that has resisted standard care.
Its limits: Most primary doctors do not provide esketamine themselves, since only certified, supervised sites may give it. The primary doctor is usually a starting point and a referral source, not the treatment site.
Your role: Get the visit booked for depression specifically, bring the medication list, and track the referral afterward.
Door two: psychiatry
Why people choose it: Expertise. Almost a quarter of respondents said they would start here.
What it is good for: A deeper evaluation and the widest range of options. A psychiatrist can prescribe and manage complex medication regimens and can evaluate someone for esketamine, TMS, or other approaches. Some psychiatry practices also run certified esketamine programs, so the evaluation and the doses happen in one building. Brain Recovery Centers explains how a Spravato treatment program works for families comparing these doors.
Its limits: Access. New patient slots can be scarce, a referral may be required, and a cold call may land you on a waitlist.
Your role: When you call, ask three things: whether they take your loved one's insurance, whether a referral is needed, and how long the wait is. If it is long, ask to be placed on a cancellation list and consider starting through primary care in parallel.
Door three: searching online
Why people choose it: Control and speed. About one in eight respondents said they would begin with their own search.
What it is good for: Learning vocabulary, finding which clinics exist in the area, and preparing questions. That is genuinely useful, especially since most people know little about these treatments. Almost three quarters of our respondents, 73 percent, had never seen the word Spravato.
Its limits: A search engine cannot evaluate your loved one. It also tends to blur very different things together. Search results for ketamine may mix FDA-approved esketamine given in certified settings with off-label IV infusions and with at-home ketamine sold through telehealth companies. Those differ in oversight, cost, and coverage. And search results rarely tell you whether a clinic is in network.
Your role: Search to prepare, not to decide. Bring what you find to a clinician.
Door four: a friend or family member
Why people choose it: Comfort. Only 1 percent of respondents would ask a friend first, yet as a persuader a close friend or relative placed second, at 18 percent.
What it is good for: Encouragement, company, and practical help. A trusted person can make the call, drive, sit in the waiting room, and help tell the story accurately once inside.
Its limits: A friend cannot evaluate, prescribe, or document anything for an insurer. Advice passed along secondhand can also blur the approved nasal spray together with off-label and at-home ketamine.
Your role: If you are the friend or family member in question, this door is you. Use your influence to get your loved one through one of the other three doors, rather than to settle the treatment question yourself.
A quick comparison
- Fastest to access: Usually primary care or online search. Psychiatry often has the longest wait.
- Most complete evaluation: Psychiatry.
- Best for paperwork and insurance history: Primary care, which tends to already have the chart.
- Most likely to confuse different treatments: Online search.
- Most trusted, according to our respondents: Their own doctor, by a wide margin.
What about the St. Peters factor?
St. Peters sits in the middle of St. Charles County, with primary care from several health systems close by and more specialty options across the river in St. Louis County. For esketamine in particular, location matters. Every dose ends with an observation period and a ride home from someone else, so the driver will make that trip regularly. Our respondents knew this; nearness to home made the two-item priority list for 43 percent. Factor distance into whichever door you choose.
The door does not have to be just one
Many families use more than one at a time: a primary care visit to start the referral, an online search to learn the vocabulary, and a call to a psychiatry practice to get on its list. That is reasonable, as long as a clinician ends up making the recommendation.
This comparison is not medical advice. The FDA approved Spravato, the esketamine brand, for depression that resists treatment, with supervised dosing at certified sites only, and a clinician who knows your loved one decides whether it or anything else fits.
If your family member is in crisis or mentions suicide, text or call 988, where counselors with the Suicide and Crisis Lifeline answer at any hour, for worried relatives as much as for the person struggling.
Methodology
Pollfish study 395586438 went to its consumer panel and closed June 23, 2026, once 443 respondents between 18 and 64 had completed it, all living in Wisconsin, Iowa, Illinois, Kansas, Ohio, Nebraska, Missouri, Minnesota, Oklahoma or Indiana. Pollfish's validation is complete. This site's publisher asked for the research and financed it.